Degussa readies Zentaris for IPO

Degussa readies Zentaris for IPO

Degussa has begun preparations for its biotech subsidiary Zentaris, to be floated on the Frankfurt Stock Exchange on June 18. The initial public offering, which values Zentaris at up to EUR290 million ($246 million), is the first stage in the sale of Degussa's pharmaceuticals subsidiary Asta Me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical Week 2001-06, Vol.163 (23), p.17-17
1. Verfasser: Hume, Claudia
Format: Magazinearticle
Sprache:eng
Schlagworte:
Chemical industry
Flotation
Initial public offerings
Subsidiaries
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Degussa has begun preparations for its biotech subsidiary Zentaris, to be floated on the Frankfurt Stock Exchange on June 18. The initial public offering, which values Zentaris at up to EUR290 million ($246 million), is the first stage in the sale of Degussa's pharmaceuticals subsidiary Asta Medica.
ISSN:0009-272X
2163-3126